Full-Time

Senior Clinical Scientist

Clinical Development

Posted on 6/3/2024

Revolution Medicines

Revolution Medicines

201-500 employees

Specializes in precision oncology therapies

Biotechnology

Senior

San Carlos, CA, USA

Required Skills
Communications
Requirements
  • BS/BA or master’s degree in a scientific discipline, or other relevant advanced degree in a health science field
  • Minimum 4 years of experience in the pharmaceutical or biotechnology industry as a clinical scientist or related role
  • Thrives in a collaborative team setting and is driven by a desire to deploy innovative approaches and technologies in a high-energy environment
  • Detail-oriented with ability to prioritize tasks and function independently as appropriate
  • Strong organizational skills and ability to interpret, discuss, and report trial/program level data effectively and identify trends
  • Proficient with software tools (Microsoft Office), Electronic Data Capture, and other custom web-based software
  • Excellent written and verbal communication skills
Responsibilities
  • Contribute to clinical development strategy and execution of the Clinical Development Plan (CDP) with a focus on early-phase development
  • Partner with cross-functional teams to conduct clinical studies, including study start-up, execution, and close-out activities, data review/analysis, and preparation of study reports
  • Contribute to the development of program-level documents, including clinical protocols, investigator’s brochure, clinical study reports, abstracts and manuscripts, presentations, and various other internal and external documents and communications as needed
  • Conduct ongoing data reviews; prepare and present summaries to internal and external stakeholders
  • Ensure trial implementation according to the protocol and analyze information to assess issues relating to protocol conduct and/or individual subject safety
  • Interact with internal and external stakeholders in support of clinical trial objectives; respond to or triage questions for appropriate escalation
  • Conduct literature reviews as needed

### Welcome to Revolution Medicines, crafting the future of oncology with precision. Our focus is on advancing RAS(ON) inhibitors and RAS Companion inhibitors, marked by the remarkable journey of our lead product, RMC-4630, through its clinical phases. Supported by a team of passionate oncology experts, we are steadfast in our mission to develop treatments that precisely target oncogenic mutations, promising a brighter, healthier tomorrow for patients everywhere. ###

Company Stage

IPO

Total Funding

$1.3B

Headquarters

Redwood City, California

Founded

2014

Growth & Insights
Headcount

6 month growth

18%

1 year growth

48%

2 year growth

98%